Web page: https://www.uni-marburg.de/de/fb20/bereiche/kks
Country: Germany
City: Marburg
Address: Not specified
Related items
Trial Projects:
- Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION)
- Lymphadenectomy in Ovarian Neoplasms (LION)
- Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-pem)
- A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer
- Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy
- A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA
Institutions: Philipps-University Marburg, Coordinating Center for Clinical Trials

Trial Projects:
- Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION)
- Lymphadenectomy in Ovarian Neoplasms (LION)
- Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-pem)
- A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA
- A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer
- Efficacy and Safety of Pegylated-Proline-Interferon Alpha 2b (AOP2014) in Maintaining Deep Molecular Remissions in Patients with Chronic Myeloid Leukemia (CML) who Discontinue ABL-Kinase Inhibitor Therapy
Web page: Not specified
Transatlantic, multi-center, placebo-controlled, randomized, double-blind clinical trial to demonstrate that transdermal nicotine treatment retards parkinson's disease progression as measured by change in total (part I, II, III) UPDRS score between baseline and after 52 weeks of study treatment plus two more months wash out (60 weeks).
Sponsor: Philipps-University Marburg
Public web page: Not specified
Start date: 17th Oct 2012
End date: 15th Sep 2016
Clinical trial to o evaluate the efficacy of AOP2014 in a randomized phase III, multicenter setting with post-study follow-up
Sponsor: Philipps-University Marburg
Public web page: Not specified
Clinical study to compare overall survival (OS) in patients with platinumsensitive recurrent ovarian cancer with a positive AGO-score randomized to tumor debulking surgery followed by chemotherapy of physician’s choice versus chemotherapy of physician’s choice alone
Sponsor: Philipps-University Marburg
Public web page: Not specified
Start date: 14th Jul 2010
End date: 17th Jan 2020
Aim of the study is to investigate if adjuvant immunoadsorption is superior to standard immunosuppressive treatment in inducing clinical remission in pemphigus.
Sponsor: Philipps-University Marburg
Public web page: Not specified
Start date: 7th Mar 2011
End date: 9th Mar 2015
Clinical study to assess the efficacy of systematic pelvic and para-aortic lymphadenectomy in patients with advanced ovarian cancer and intra-abdominal complete debulking.
Sponsor: Philipps-University Marburg
Public web page: Not specified
Start date: 12th Dec 2008
End date: 31st Mar 2018